This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1.A von Ruesten , S Feller , MM Bergmann , et al. (2013) Diet and risk of chronic diseases: results from the first 8 years of follow-up in the EPIC-Potsdam study. Eur J Clin Nutr 67, 412–419.
2.KN Grooms , MJ Ommerborn , DQ Pham , et al. (2013) Dietary fiber intake and cardiometabolic risks among US adults, NHANES 1999–2010. Am J Med 126, 1059–1067 (e1–4).
4.K Harris Jackson , SG West , JP Vanden Heuvel , et al. (2014) Effects of whole and refined grains in a weight-loss diet on markers of metabolic syndrome in individuals with increased waist circumference: a randomized controlled-feeding trial. Am J Clin Nutr 100, 577–586.
5.PD Cani , A Everard & T Duparc (2013) Gut microbiota, enteroendocrine functions and metabolism. Curr Opin Pharmacol 13, 935–940.
6.G Tolhurst , H Heffron , YS Lam , et al. (2012) Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 61, 364–371.
7.AH Sam , RC Troke , TM Tan , et al. (2012) The role of the gut/brain axis in modulating food intake. Neuropharmacology 63, 46–56.
8.JJ Holst (2007) The physiology of glucagon-like peptide 1. Physiol Rev 87, 1409–1439.
9.SJ Persaud & GA Bewick (2014) Peptide YY: more than just an appetite regulator. Diabetologia 57, 1762–1769.
10.PD Cani , S Possemiers , T Van de Wiele et al. (2009) Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58, 1091–1103.
12.TW Schwartz & B Holst (2010) An enteroendocrine full package solution. Cell Metab 11, 445–447.
13.A Psichas , ML Sleeth , KG Murphy , et al. (2014) The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents. Int J Obes (Lond) 39, 424–429.
15.PD Cani , E Lecourt , EM Dewulf , et al. (2009) Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr 90, 1236–1243.
17.EV Johansson , AC Nilsson , EM Ostman , et al. (2013) Effects of indigestible carbohydrates in barley on glucose metabolism, appetite and voluntary food intake over 16 h in healthy adults. Nutr J 12, 46.
18.A Nilsson , E Johansson , L Ekstrom , et al. (2013) Effects of a brown beans evening meal on metabolic risk markers and appetite regulating hormones at a subsequent standardized breakfast: a randomized cross-over study. PLoS ONE 8, e59985.
19.J Holm , IME Björck , A Drews , et al. (1986) A rapid method for the analysis of starch. Starch/Stärke 38, 224–226.
20.IME Björck & MA Siljeström (1992) In-vivo and in-vitro digestibility of starch in autoclaved pea and potato products. J Sci Food Agric 58, 541–553.
22.N-G Asp , C-G Johansson , H Hallmer , et al. (1983) Rapid enzymatic assay of insoluble and soluble dietary fiber. J Agric Food Chem 31, 476–482.
24.DR Matthews , JP Hosker , AS Rudenski , et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419.
25.M Matsuda & RA DeFronzo (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22, 1462–1470.
26.RA DeFronzo & M Matsuda (2010) Reduced time points to calculate the composite index. Diabetes Care 33, e93.
29.MO Weickert , M Roden , F Isken , et al. (2011) Effects of supplemented isoenergetic diets differing in cereal fiber and protein content on insulin sensitivity in overweight humans. Am J Clin Nutr 94, 459–471.
30.MO Weickert , M Mohlig , C Koebnick , et al. (2005) Impact of cereal fibre on glucose-regulating factors. Diabetologia 48, 2343–2353.
31.A Mansour , S Hosseini , B Larijani , et al. (2013) Nutrients related to GLP1 secretory responses. Nutrition 29, 813–820.
32.JJ Holst & MA McGill (2012) Potential new approaches to modifying intestinal GLP-1 secretion in patients with type 2 diabetes mellitus: focus on bile acid sequestrants. Clin Drug Investig 32, 1–14.
33.KL Egerod , MS Engelstoft , KV Grunddal , et al. (2012) A major lineage of enteroendocrine cells coexpress CCK, secretin, GIP, GLP-1, PYY, and neurotensin but not somatostatin. Endocrinology 153, 5782–5795.
34.I Kaji , S Karaki & A Kuwahara (2014) Short-chain fatty acid receptor and its contribution to glucagon-like peptide-1 release. Digestion 89, 31–36.
36.C Orskov , B Hartmann , SS Poulsen , et al. (2005) GLP-2 stimulates colonic growth via KGF, released by subepithelial myofibroblasts with GLP-2 receptors. Regul Pept 124, 105–112.
37.PD Cani , J Amar , MA Iglesias , et al. (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56, 1761–1772.
38.A Everard & PD Cani (2013) Diabetes, obesity and gut microbiota. Best Pract Res Clin Gastroenterol 27, 73–83.
39.PD Cani (2012) Crosstalk between the gut microbiota and the endocannabinoid system: impact on the gut barrier function and the adipose tissue. Clin Microbiol Infect 18, 50–53.